Beirut, Lebanon Clinical Trials

A listing of Beirut, Lebanon clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

A committee will judge the safety and effectiveness of edoxaban and the regular treatment (standard of care). All children in the study will receive free treatment. They will have a 2 in 3 chance to receive edoxaban, and a 1 in 3 chance to receive the standard of care for …

thrombosis
heart failure
secondary prevention
primary prevention
Sheba Medical Center
 (131.6 away) Contact site
  • 40 views
  • 26 Jan, 2021
  • +62 other locations
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).

lung carcinoma
alopecia
systemic therapy
Novartis Investigative Site
 (1.1 away) Contact site
  • 645 views
  • 03 Jun, 2021
  • +406 other locations
Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD

This is a prospective, non-controlled, international, multi-center phase 3 study investigating the efficacy and safety of Wilate in previously treated adult patients with VWD, to obtain additional data on the safety and efficacy of Wilate in previously treated patients with VWD undergoing regular prophylaxis.

substitution therapy
control bleeding
von willebrand factor
ristocetin
Nini Hospital
 (41.8 away) Contact site
  • 45 views
  • 08 Apr, 2021
  • +13 other locations
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prostate Cancer Participants

The main purpose of this study is to determine if the addition of apalutamide to radiotherapy (RT) plus luteinizing hormone-releasing hormone agonist (LHRHa) delays metastatic progression as assessed by prostate specific membrane antigen-positron emission tomography (PSMA-PET) or death compared with RT plus LHRHa alone.

St Georges Hospital university medical centre
 (0.5 away) Contact site
  • 0 views
  • 15 Jun, 2021
  • +98 other locations
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in participants with Idiopathic Pulmonary Fibrosis (IPF). There is a 48-week randomized treatment phase followed by an optional, open-label extension phase.

carbon monoxide
pirfenidone
pamrevlumab
idiopathic pulmonary fibrosis
nintedanib
Research Center
 (1.9 away) Contact site
  • 0 views
  • 14 Jun, 2021
  • +53 other locations
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to assess the efficacy of etrasimod on clinical remission in participants with moderately to severely active ulcerative colitis (UC).

remission
endoscopy
Hotel Dieu de France Hospital
 (0.5 away) Contact site
  • 12 views
  • 06 Jun, 2021
  • +414 other locations
A Study of IMR-687 in Subjects With Sickle Cell Disease

A Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease

thalassemia
Chronic Care Center
 (3.3 away) Contact site
  • 12 views
  • 04 Mar, 2021
  • +21 other locations
Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R or Chronic Myelomonocytic Leukemia-2 (CMML-2)

This is a Phase III multi-center, randomized, two-arm parallel-group, double-blind, placebo-controlled study of MBG453 or placebo added to azacitidine in adult subjects with intermediate, high or very high risk myelodysplastic syndrome (MDS) as per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) who have an indication for treatment with azacitidine in first-line …

azacitidine
chronic myelomonocytic leukemia
stem cell transplantation
cmml-2
cell transplantation
Novartis Investigative Site
 (89.2 away) Contact site
  • 5 views
  • 12 Jun, 2021
  • +118 other locations
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

The purpose of this extension study is to establish efficacy and safety of ligelizumab. This will be assessed in adult and adolescent chronic spontaneous urticaria (CSU) patients who have completed a preceding ligelizumab study and have relapsed, following treatment in these preceding studies, despite standard of care H1-antihistamine (H1-AH) treatment. …

urticaria
ligelizumab
antihistamines
Novartis Investigative Site
 (0.8 away) Contact site
  • 0 views
  • 15 Jun, 2021
  • +215 other locations
Safety Tolerability Pharmacokinetics (PK) Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in -thalassaemia

This is a randomised, double-blind, placebo-controlled parallel group trial to investigate the safety, tolerability and efficacy of multiple doses of VIT-2763 versus placebo in participants with non-transfusion-dependent Beta-thalassemia (NTDT).

thalassemia intermedia
blood transfusion
Clinical Site #402
 (81.2 away) Contact site
  • 17 views
  • 14 Jun, 2021
  • +15 other locations